FMTX Insider Trading Activity and SEC Form 4 Filings
FMTX insider trading summary
No open-market insider purchases or sales of Forma Therapeutics Holdings, Inc. (FMTX) have been reported on SEC Form 4 in the past 12 months.
Latest FMTX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 23, 2022 | Frank D. Lee | President and CEO | Sell | $176K (17,981 @ $9.78) |
| Feb 23, 2022 | Todd Shegog | SVP, Chief Financial Officer | Sell | $56K (5,687 @ $9.78) |
| Feb 23, 2022 | David N Cook | SVP, Chief Scientific Officer | Sell | $35K (3,531 @ $9.78) |
| Feb 23, 2022 | Patrick F. Kelly | SVP, Chief Medical Officer | Sell | $51K (5,245 @ $9.78) |
| Feb 23, 2022 | Jeannette Potts | See Remarks | Sell | $46K (4,672 @ $9.78) |
| Feb 23, 2022 | Mary E. Wadlinger | See Remarks | Sell | $46K (4,684 @ $9.78) |
| Feb 23, 2022 | Brian Andrew Lesser | SVP, Commercial | Sell | $38K (3,837 @ $9.78) |
| Jun 23, 2020 | Marsha Fanucci | Director | Sell | $0 (9,847 @ $0.00) |
| Jun 23, 2020 | RA Capital Healthcare Fund LP | 10% Owner | Buy | $80.0M (4,000,000 @ $20.00) |
| Jun 23, 2020 | Marsha Fanucci | Director | Sell | $0 (33,781 @ $0.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.